{
    "2020-12-30": [
        [
            {
                "time": "2021-03-01",
                "original_text": "定增市场周报：竞价发行难度上升：募足率骤降 折价率下滑",
                "features": {
                    "keywords": [
                        "定增",
                        "竞价发行",
                        "募足率",
                        "折价率"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-02",
                "original_text": "728亿主力资金近三日撤出全A(等权)概念股",
                "features": {
                    "keywords": [
                        "主力资金",
                        "撤出",
                        "全A",
                        "概念"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-03",
                "original_text": "复星医药(02196)：苏州基金的认缴出资额将增加至约9.26亿元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "苏州基金",
                        "认缴出资"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-04",
                "original_text": "复星医药(02196)拟为控股子公司复星实业提供担保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "担保",
                        "复星实业"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "复星医药(02196.HK)拟为复星实业不超3000万美元贷款授信提供担保 大额借贷担保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "担保",
                        "贷款授信"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-06",
                "original_text": "一年28位药企掌门人离职，76%新冠患者出院半年仍有症状",
                "features": {
                    "keywords": [
                        "药企",
                        "离职",
                        "新冠",
                        "症状"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-07",
                "original_text": "ST舍得与天洋控股“分手”在即：传川酒集团、复星集团将参与竞拍",
                "features": {
                    "keywords": [
                        "ST舍得",
                        "天洋控股",
                        "川酒集团",
                        "复星集团",
                        "竞拍"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-08",
                "original_text": "与天洋控股“分手”在即，被摆上货架的ST舍得接盘方依然扑朔迷离",
                "features": {
                    "keywords": [
                        "ST舍得",
                        "天洋控股",
                        "接盘方"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-09",
                "original_text": "医药行业周报：第四批仿制药集采拉开序幕 新版医保目录尘埃落定",
                "features": {
                    "keywords": [
                        "医药",
                        "仿制药",
                        "集采",
                        "医保目录"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-10",
                "original_text": "烧钱博弈疫苗！复星医药：你不是药神",
                "features": {
                    "keywords": [
                        "复星医药",
                        "疫苗",
                        "烧钱"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-11",
                "original_text": "【医药】第四批仿制药集采拉开序幕，新版医保目录尘埃落定――医药行业周报——中报",
                "features": {
                    "keywords": [
                        "医药",
                        "仿制药",
                        "集采",
                        "医保目录"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-30",
                "original_text": "智通港股通持股分析|12月30日",
                "features": {
                    "keywords": [
                        "港股通",
                        "持股分析"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-12",
                "original_text": "一级市场也“醉酒”，新派白酒成新宠",
                "features": {
                    "keywords": [
                        "一级市场",
                        "白酒",
                        "新派"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}